There are many methods for spectral analysis and imaging of skin anomalies in limited use or under development. These methods include optical spectral and thermal imaging, visible and infrared, electromagnetic microwave, acoustic, magnetic, ultraviolet X-rays and others.
Several new technologies are at relatively early stages of development. These include developments by companies such as MELA Sciences Inc., and Balter Medical.
Most of these methods still rely mainly on the enlarged digital or optical photograph which is basically improving the Doctors subjective assessment.
A few methods use various combinations of processing spectral reflectance backed by a database of photographs of different types of skin cancers.
These methods can give a standardized diagnosis with a risk of not being able to diagnose the specific differences between each and every patient.
All this results in an increase of false diagnosis.
The best thing about the SkinScan 650 is that it does not rely on anything other than the information the diagnosed patients’ skin itself gives us. All the information is gathered from the examined lesion. The device uses spectral reflectance technology to diagnose the scanned lesions. That means that light rays reflected from the scanned body send signals to our device. The signals are collected and analyzed by a unique set of algorithms which recognize various lesion patterns and define each one.
The results will allow the device to define benign and malignant lesions and non-melanoma skin cancers on the spot.
No unnecessary anxiety waiting for the results. No risk of scarring. No unwelcome pain. No additional costs.
The fact that there is no need for surgical biopsies means fewer complications. And because the technology measures the lesion on the spot, it also means shorter waiting time for results.